TAT and hepatocellular carcinoma: Our results demonstrated that two autophagy-inducing stapled peptides, Tat-SP4 and Tat-SP9, readily induced autophagy in both wild-type and Sorafenib-resistant HCC cells and inhibited their proliferation with comparable potency.